Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04116684 · ClinicalTrials.gov registry record · NA
Digital Home Blood Pressure Monitoring in Type B Aortic Dissection Patients
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04116684: Clinical Trial NA study, sponsored by The Cleveland Clinic.
NCT04116684 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04116684, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the effectiveness of home digital blood pressure monitoring in aiding providers to maintain blood pressure within a therapeutic range in type B aortic dissection patients upon discharge from the hospital.
Primary Outcome
Systolic Blood Pressure at end of 4 weeks as measured by 24 hour ambulatory cuff.
Interventions
- DEVICE Withings Digital Blood Pressure Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-09-23 |
| Est. Completion | 2021-01-20 |
| Phase | NA |
Why NCT04116684 stopped before completion
NCT04116684 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Withings Digital Blood Pressure Monitor is the first listed.
NCT04116684 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04116684 about?
NCT04116684 is a clinical study titled "Digital Home Blood Pressure Monitoring in Type B Aortic Dissection Patients". The primary objective of this study is to determine the effectiveness of home digital blood pressure monitoring in aiding providers to maintain blood pressure within a therapeutic range in type B aortic dissection patients upon discharge from the hospital.
What is the current status of trial NCT04116684?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2019-09-23. Estimated completion is 2021-01-20.
What interventions are being tested in trial NCT04116684?
The interventions under investigation include: Withings Digital Blood Pressure Monitor (DEVICE).
Who is sponsoring clinical trial NCT04116684?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04116684's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI